BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jadaon MM. Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr J Hematol Infect Dis 2011;3:e2011054. [PMID: 22220251 DOI: 10.4084/MJHID.2011.054] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Parsa A, Nazal MR, Stelzer JW, Sieff CA, Martin SD. A Successful Collaborative Approach to the Perioperative Management After Hip Arthroscopy of a Patient with Heterozygous Prothrombin G20210A Mutation: A Case Report. JBJS Case Connect 2019;9:e0376. [PMID: 31085938 DOI: 10.2106/JBJS.CC.18.00376] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 El-Din Hamdy MS, Nasr AS, Makhlouf MM, El-Saadany ZA, Samir M, Morgan DS. Impact of Prothrombotic Risk Factors in a Cohort of Egyptian Hemophilia A Patients. Mol Diagn Ther 2016;20:151-9. [PMID: 26891731 DOI: 10.1007/s40291-015-0185-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Poudel S, Zeb M, Kondapaneni V, Gutlapalli SD, Choudhari J, Sodiya OT, Toulassi IA, Cancarevic I. Association of G20210A Prothrombin Gene Mutation and Cerebral Ischemic Stroke in Young Patients. Cureus 2020;12:e11984. [PMID: 33437541 DOI: 10.7759/cureus.11984] [Reference Citation Analysis]
4 Yan AR, Samarawickrema I, Naunton M, Peterson GM, Yip D, De Rosa S, Mortazavi R. Risk Factors and Prediction Models for Venous Thromboembolism in Ambulatory Patients with Lung Cancer. Healthcare (Basel) 2021;9:778. [PMID: 34205695 DOI: 10.3390/healthcare9060778] [Reference Citation Analysis]
5 Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism. Thromb Haemost 2015;114:901-9. [PMID: 26156046 DOI: 10.1160/TH15-04-0330] [Cited by in Crossref: 31] [Cited by in F6Publishing: 13] [Article Influence: 5.2] [Reference Citation Analysis]
6 Al-Allawi NA, Badi AI, Goran MA, Nerweyi FF, Ballo HM, Al-Mzury NT. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients. Genet Test Mol Biomarkers 2015;19:500-4. [PMID: 26196588 DOI: 10.1089/gtmb.2015.0099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Dubský M, Jirkovská A, Pagáčová L, Bém R, Němcová A, Fejfarová V, Wosková V, Jude EB. Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes. J Diabetes Res 2015;2015:369758. [PMID: 26247037 DOI: 10.1155/2015/369758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Gunathilake KM, Sirisena UN, Nisansala PK, Goonasekera HW, Jayasekara RW, Dissanayake VH. The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders. Indian J Hematol Blood Transfus 2015;31:356-61. [PMID: 26085721 DOI: 10.1007/s12288-014-0452-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Glueck CJ, Freiberg RA, Boriel G, Khan Z, Brar A, Padda J, Wang P. The role of the factor V Leiden mutation in osteonecrosis of the hip. Clin Appl Thromb Hemost 2013;19:499-503. [PMID: 22696591 DOI: 10.1177/1076029612449901] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
10 Romiti GF, Corica B, Borgi M, Visioli G, Pacella E, Cangemi R, Proietti M, Basili S, Raparelli V. Inherited and acquired thrombophilia in adults with retinal vascular occlusion: A systematic review and meta-analysis. J Thromb Haemost 2020;18:3249-66. [PMID: 32805772 DOI: 10.1111/jth.15068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lenz B, Samardzija M, Drenjancevic D, Zibar D, Samardzija M, Milostic-srb A. The investigation of hereditary and acquired thrombophilia risk factors in the development of complications in pregnancy in Croatian women. The Journal of Maternal-Fetal & Neonatal Medicine 2016;29:264-9. [DOI: 10.3109/14767058.2014.998189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Rudolf J, Jackson BR, Wilson AR, Smock KJ, Schmidt RL. Organizational Benchmarks for Test Utilization Performance. American Journal of Clinical Pathology 2017;147:382-9. [DOI: 10.1093/ajcp/aqx019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Kallel A, Sbaï MH, Sédiri Y, Feki M, Mourali MS, Mechmeche R, Jemaa R, Kaabachi N. Association Between the G20210A Polymorphism of Prothrombin Gene and Myocardial Infarction in Tunisian Population. Biochem Genet 2016;54:653-64. [PMID: 27306359 DOI: 10.1007/s10528-016-9744-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Réger B, Losonczy H, Nagy Á, Péterfalvi Á, Mózes R, Pótó L, Farkas N, Kovács GL, Miseta A, Hussain A, Tóth O. Detection of high-risk thrombophilia with an automated, global test: the Coagulation Inhibitor Potential assay. Blood Coagul Fibrinolysis 2018;29:435-41. [PMID: 29782332 DOI: 10.1097/MBC.0000000000000738] [Reference Citation Analysis]
15 Dueppers P, Grabitz K, Li Y, Schelzig H, Wagenhäuser MU, Duran M. Surgical management of iliofemoral vein thrombosis during pregnancy and the puerperium. J Vasc Surg Venous Lymphat Disord 2016;4:392-9. [PMID: 27638991 DOI: 10.1016/j.jvsv.2016.06.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
16 Santoro F, Tarantino N, Ieva R, Musaico F, Di Biase M, Brunetti ND. Hereditary hypercoagulable state and Takotsubo cardiomyopathy: a possible link. Int J Cardiol 2014;174:e108-9. [PMID: 24820744 DOI: 10.1016/j.ijcard.2014.04.198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
17 Russo PD, Damante G, Pasca S, Turello M, Barillari G. Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion: A Case–Control Study. Clin Appl Thromb Hemost 2015;21:373-7. [DOI: 10.1177/1076029614522544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
18 George MG. Risk Factors for Ischemic Stroke in Younger Adults: A Focused Update. Stroke 2020;51:729-35. [PMID: 32078487 DOI: 10.1161/STROKEAHA.119.024156] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 29.0] [Reference Citation Analysis]
19 Hoteit R, Hassanieh S, Mahfouz RA. Comparison of the performance of the Cepheid Xpert HemosIL Factor II and Factor V and the ViennaLab FV-PTH-MTHFR StripAssay kits for molecular thrombophilia profiling. Genet Test Mol Biomarkers 2014;18:183-6. [PMID: 24401045 DOI: 10.1089/gtmb.2013.0379] [Reference Citation Analysis]
20 Moussaoui S, Saussoy P, Ambroise J, Defour JP, Zouitene R, Sifi K, Abadi N. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population. Clin Appl Thromb Hemost 2017;23:105-15. [DOI: 10.1177/1076029615600789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Trasca LF, Patrascu N, Bruja R, Munteanu O, Cirstoiu M, Vinereanu D. Therapeutic Implications of Inherited Thrombophilia in Pregnancy. Am J Ther 2019;26:e364-74. [PMID: 30985485 DOI: 10.1097/MJT.0000000000000985] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]